Atul Bio Space Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 11.03 Cr
as on 11-12-2024
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 10.66%
(FY 2022)
- Profit -4.21%
(FY 2022)
- Ebitda -10.69%
(FY 2022)
- Net Worth 4.67%
(FY 2022)
- Total Assets 6.56%
(FY 2022)
About Atul Bio Space
The Corporate was formerly known as Atul Bio Space Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 11.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Atul Bio Space Limited India are Sunil Rathor as COMPANY SECRETARY and Alok Porwal as Cfo. Bharathy Mohanan, Sunil Joshi, and Ajitsingh Batra serve as directors at the Company.
- CIN/LLPIN
U01500GJ2005PLC045244
- Company No.
045244
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2005
- Date of AGM
08 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Atul Bio Space?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bharathy Mohanan | Managing Director | 18-Apr-2006 | Current |
Sunil Rathor | Company Secretary | 17-Feb-2020 | Current |
Alok Porwal | CFO | 03-Jan-2018 | Current |
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunil Joshi | Director | 18-Apr-2006 | Current |
Ajitsingh Batra | Director | 25-Mar-2009 | Current |
Financial Performance and Corporate Structure Insights of Atul Bio Space.
Atul Bio Space Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.66% increase. The company also saw a slight decrease in profitability, with a 4.21% decrease in profit. The company's net worth moved up by a moderate rise of 4.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Atul Bio Space?
In 2022, Atul Bio Space had a promoter holding of 100.00%. The company had 4 Subsidiaries and 4 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Atul Bio Space?
Unlock and access historical data on people associated with Atul Bio Space, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atul Bio Space, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atul Bio Space's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.